First Time Loading...
T

Teva Pharmaceutical Industries Ltd
TASE:TEVA

Watchlist Manager
Teva Pharmaceutical Industries Ltd
TASE:TEVA
Watchlist
Price: 5 870 ILS 0.95% Market Closed
Updated: May 11, 2024

Teva Pharmaceutical Industries Ltd
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Teva Pharmaceutical Industries Ltd
Interest Income Expense Peer Comparison

Comparables:
TARO
I
INCR
MDWD
R
REKA
C
CSURE

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
T
Teva Pharmaceutical Industries Ltd
TASE:TEVA
Interest Income Expense
-$991m
CAGR 3-Years
-6%
CAGR 5-Years
-2%
CAGR 10-Years
-10%
Taro Pharmaceutical Industries Ltd
NYSE:TARO
Interest Income Expense
$48.5m
CAGR 3-Years
23%
CAGR 5-Years
-10%
CAGR 10-Years
18%
I
InterCure Ltd
TASE:INCR
Interest Income Expense
-₪24.2m
CAGR 3-Years
-117%
CAGR 5-Years
-56%
CAGR 10-Years
N/A
Mediwound Ltd
NASDAQ:MDWD
Interest Income Expense
$9.7m
CAGR 3-Years
126%
CAGR 5-Years
120%
CAGR 10-Years
N/A
R
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Interest Income Expense
-₪12.2m
CAGR 3-Years
-17%
CAGR 5-Years
-22%
CAGR 10-Years
-6%
C
Cannassure Therapeutics Ltd
TASE:CSURE
Interest Income Expense
-₪1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Teva Pharmaceutical Industries Ltd's Interest Income Expense?
Interest Income Expense
-991m USD

Based on the financial report for Dec 31, 2023, Teva Pharmaceutical Industries Ltd's Interest Income Expense amounts to -991m USD.

What is Teva Pharmaceutical Industries Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
-10%

Over the last year, the Interest Income Expense growth was -10%. The average annual Interest Income Expense growth rates for Teva Pharmaceutical Industries Ltd have been -6% over the past three years , -2% over the past five years , and -10% over the past ten years .